Seegnal Inc. Announces Extension and Expansion of Maccabi Health Services Contract
Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in SaaS clinical division support solutions, is pleased to announce that effective September 8, 2025, it has amended its contract with Maccabi Health Services ("Maccabi") for an additional six years and has also expanded the scope of the contract to include all of Maccabi's pharmacies and additional nurses. Maccabi is the second largest Healthcare Management Organization ("HMO") in Israel, serving over 2.6 million Israelis and is renowned for its use of technology and emphasis on patient-centered care, according to Maccabi's website here.
Pursuant to the amended agreement, Seegnal will continue to deliver its patented prescription co-pilot platform for an additional six years, to September 22, 2031, while expanding the scope to nurses and pharmacists in all of Maccabi's nationwide pharmacies. Maccabi is the first in Israel and one of the first HMOs worldwide to offer an end-to-end safety coverage throughout the patient journey, allowing complete visibility to pharmacists in the pharmacies into clinician decision while prescribing patient centric medication. The expanded contract was changed from a fixed base contract to Seegnal's current SaaS based model based on Quarterly Recurring License Fees and is expected to generate additional revenue for the Corporation.
“This partnership is a testament to the measurable impact Seegnal delivers for Healthcare providers who adopt a high patient-centric standard at the point of care over the traditional Drug-to-Drug Interaction (DDI) standard,” said Eyal Schneid, CEO of Seegnal. “We’re proud to deepen our relationship with Maccabi Health Services and bring even greater precision, safety, and efficiency to their clinical and operative workflows. This expansion also reinforces our strategic growth trajectory and positions us to scale our impact across broader markets.”
Mr. Schneid added, “The new agreement extends through September 22, 2031, with an option for Maccabi to extend it further by two years under the current terms. It broadens the integration beyond the Electronic Health Record (EHR) to the ERP system nationwide. It reflects growing demand for Seegnal’s platform, which in a 2021 study published in the US National Library of Medicine titled “Comparison of Medication Alerts from Two Commercial Applications in the USA” and located online here, demonstrated the ability to reduce alert load by up to 94%, lower medication-related costs, and improve clinician satisfaction—key metrics that align with value-based care initiatives and payer priorities.”
"Maccabi Health Services has been a partner in embracing customer-centric medication standards," added Schneid. "Together, we're setting a new standard for proactive, patient-specific care. This milestone further validates our commercial strategy and underscores the scalability of our technology."